In the meantime, several groups could prevent tumour development—or suppress inflammatory responses in autoimmune patients—by using different sources of exosomes such as plasmacytoma cell-derived exosomes or exosomes derived from IL-10-treated DCs [156, 170]. The gene discussed is IL10; the disease is plasmacytoma.